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a  b  s  t  r  a  c  t
Aim: To present the results obtained using radiochromic ﬁlms EBT and RTQA 1010P for the
reconstruction the dose distributions for targets irradiated by proton beam and modiﬁed by
wax  boluses.
Background: In Medico-Technical Complex at the Joint Institute for Nuclear Research in
Dubna implemented technology of wax boluses.
Materials and methods: Wax boluses are easier to make and they give better dose distributions
than boluses made from modeling clay previously used at our center. We irradiated two
imaginary targets, one shaped as a cylinder and the other one as two cuboids. The evaluated
calibration curve was used for calculation of the dose distributions measured by the EBT and
RTQA radiochromic ﬁlm. In both cases, the measured dose distributions were compared to
the  dose distributions calculated by the treatment planning system (TPS). We  also compared
dose  distributions using three different conformity indices at a 95% isodose.
Results: Better target coverage and better compliance of measurements (semiconductor
detectors and radiochromic ﬁlms) with calculated doses was obtained for cylindrical tar-
get  than for cuboidal target. The 95% isodose covered well the tumor for both target shapes,
while  for cuboidal target larger volume around the target received therapeutic dose, due to
the  complicated target shape. The use wax boluses provided to be effective tool in modifying
proton beam to achieve appropriate shape of isodose distribution.Conclusion: EBT ﬁlm yielded the best visual matching. Both EBT and RTQA ﬁlms conﬁrmed
good  conformity between calculated and measured doses, thus conﬁrming that wax bolusesused  to modify the proton
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.  Background
roton beam radiotherapy (PBRT) has gathered much attention
n recent years due to its theoretical advantages over conven-
ional external beam radiotherapy (EBRT). In contrast to EBRT,
n which much of the energy is absorbed by healthy tissue
s the beam passes through on its way to the target, in PBRT
ost of the energy is delivered to the target. This pattern of
nergy deposition, known as the Bragg peak, makes proton
herapy especially advantageous in the treatment of tumors
urrounded by critical structures.1,2 For this reason, PBRT is
eing used in pediatric patients to prevent radiation-induced
econdary tumors3,4 and increasingly in some head and neck
umors as well as for prostate cancer. The major drawback of
BRT is signiﬁcantly higher price of technology required and
lso more  complicated dosimetry and quality procedures.2,5,6
n the meantime photon and electron radiotherapy has devel-
ped enormously and can offer sophisticated tools which
llow on very accurate dose delivery to the target with sub-
tantial reduction of dose to critical organs.7–13
An important issue in PBRT is in achieving dose conformity
n the distal part of the tumor. This difﬁculty can be overcome
y the use of a bolus, which is used to account for heteroge-
ous tissue in the path of the beam and to adapt the proton
ange to the shape of the tumor. The ideal bolus should be
ade of safe, tissue-equivalent material that is durable, cost-
ffective, and sufﬁciently ﬂexible to conform to the patient’s
ody. Up until quite recently, at our center boluses were made
f modeling clay. However, the high plasticity and low melting
oint were sometimes problematic. In addition, the bolus was
ormed partially by hand and thus lacked precision. To over-
ome these shortcomings, we recently switched to a different
aterial – special wax for machine processing. Wax boluses
ave numerous theoretical advantages: they are milled by a
omputerized machine that produces a precisely-made bolus
n accordance with the treatment plan coordinates (x, y, z). In
ddition, wax boluses have a higher melting point than mod-
ling clay boluses (116 ◦C vs. 65 ◦C), and they are more  resistant
o mechanical injury.
Accurate dose determination and precise dose delivery
re essential in all types of radiotherapy,7 but particularly
n PBRT due to the patterns of energy deposition. For this
eason, numerous dose veriﬁcation and calibration methods
ave been created. ICRU 59 describes the use of ionization
hambers for proton dosimetry,8 although other methods,
uch as semiconducting detectors, can be used for this pur-
ose. However, in recent years, improvements in radiochromic
lm (RCF) dosimetry have made this technique a powerful
ool for treatment veriﬁcation and quality assurance. RCFs
re used in conventional radiotherapy with photons, but they
re also good detectors for the dosimetry of the proton beam
ecause they can be positioned along the beam axis in a water
hantom.9,14 Several authors have described different types
f radiochromic ﬁlms to measure proton dosimetry, including
atnitsky et al.15 and Ciangaru et al.16 The advantages of RFCs
re that they are sensitive to ionizing radiation, and change
olor in response to the delivered radiation, with darker colors
ndicative of higher doses. Moreover, RCFs are easy to handle
nd prepare because they are not sensitive to room lights, theyiotherapy 1 9 ( 2 0 1 4 ) 12–18 13
develop automatically (unlike radiographic ﬁlms), and facili-
tate reading of the absorbed dose. Several different types of
RCF have been developed, with two of the most common being
EBT and RTQA radiochromic ﬁlms.17
2.  Aim
The present study had two primary aims: (1) to evaluate the
ability of wax boluses to produce a speciﬁc dose distribution;
and (2) to compare two types of radiochromic ﬁlms used to
verify the accuracy of the calculation algorithm for the proton
beam at our center (Medico-Technical Complex of the Joint
Institute for Nuclear Research at Dubna, Russia).
3.  Materials  and  methods
3.1.  Treatment  planning  system,  targets,  conditions  of
irradiation
We  used the TPN 3D treatment planning system (TPS), devel-
oped at the Loma-Linda University Medical Center, California,
USA. This TPS was adapted for proton beams delivered by the
JINR Phasotron with output energy of 660 MeV.  For medical
applications the energy of protons is reduced to 175 MeV  and
such beam was used in the study.
For this study, we created two distinct shapes for the irra-
diated targets and a separate treatment plan for each of them.
Both shapes were basic geometric ﬁgures with a volume of
about 125 cm3, and they are shown in Fig. 1.
Measurements were made in an almost tissue-equivalent
environment (water). The geometric targets were virtu-
ally immersed in a PMMA tank with internal volume of
254 mm × 160 mm × 201 mm produced at the MTC workshop.
The tank was ﬁlled with water for the irradiation process. We
used a 60 mm × 60 mm collimator with a ridge ﬁlter to spread-
out the proton beam Bragg peak to the size of targets.
3.2.  Wax  boluses
Boluses are produced individually for each patient and for
each irradiation angle. Boluses were mechanically milled to
match the coordinates calculated by the TPS. The boluses used
in the study are presented in Fig. 2.
3.3.  Dosimeters
We  used two types of RC ﬁlms: EBT and RTQA 1010P (Inter-
national Specialty Products, Wayne, NJ, USA) to measure dose
distributions. These ﬁlms can be used in a water environment
because the ﬁlm layers are not affected by water. EBT ﬁlm con-
sists of two active layers (i.e., responsive to radiation) and two
outer layers of transparent polyester. RTQA ﬁlm has one active
layer and one layer of transparent polyester, colored in yellow
and one layer of white nontransparent polyester.3.4.  Calibration  of  detectors
Films were cut into 8 small pieces 20 mm × 20 mm  in dimen-
sion and were irradiated with the following doses: EBT ﬁlms
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Fig. 1 – Shapes of irradiated targets: (a) a cylinder with the diameter of 50 mm;  (b) two cuboids with base square
25 mm × 25 mm offset from each other by 15 mm.
es used in the study.Fig. 2 – The bolus
(0-3.0 Gy) and RTQA (0-3.5 Gy). These small pieces were used to
deﬁne how the ﬁlm responds to the indicated dose and to cali-
brate the detectors and scanner at the same time. One piece of
each type of radiochromic ﬁlm was left unirradiated in order
to characterize a 0 Gy dose. The other pieces were irradiated
perpendicularly to the central axis of the beam. Forty-eight
hours after irradiation, the pieces were scanned and the red
channel (which offers the highest absorption) was extracted
from the Red–Green–Blue bitmap using dedicated software for
image processing and analysis in Java (ImageJ) and pixel val-
ues were read in order to calculate the relative optical density
(ROD) and to draw the calibration curve (representing the rela-
tion between ROD and dose, as shown in Fig. 3). The ﬁlms were
scanned on the ﬂatbed scanner (HP Ofﬁcejet 7213).
3.5.  Dose  distribution  measurementsNext, larger pieces (100 mm × 170 mm in dimension) were cut
from an RCF sheet and were irradiated with a 3 Gy dose (at
the isocenter) in order to verify dose distributions. Films were
places in the water phantom and positioned with a 5◦ slopeFig. 3 – Calibration curves for EBT and RTQA radiochromic
ﬁlms.

































sFig. 4 – Dose distributions of TPS and semico
o the beam axis in the horizontal plane, which prevented
 formation of air gaps under the ﬁlms. After 48 h, all ﬁlms
ere scanned with the same orientation on a 48-bit ﬂat bed
canner at a resolution of 200 dpi. To perform veriﬁcation of
he dose distributions, we created bitmaps from the scanned
mages, reduced the resolution to correspond the resolution
f the calculated dose ﬁelds, and cut the red channel.
For comparative purposes, we  also used high-doped p-type
ilicon semiconductor detector (<1 mm thick) to measure dose
istributions. The detector was placed in the water phantom
nd was continuously repositioned during irradiation (via a
mall motor) perpendicularly to the beam axis in steps of 3 mm
nd parallel to the axis with steps of 5 mm.  Position of detector
as changed to measure a level of dose in different points and
ext to create 2D dose distribution map  parallel to the beam
xis.
.6.  Dose  distribution  comparison
o verify the ﬁt of the dose distribution to the target for
eams modiﬁed by wax boluses, we  analyzed the coverage
f the tumor by the isodose of 95%. Use of the 95% isodose
s reference value corresponded well with the methodology
f ﬁtting “dose to structures” with the use of conformity
ndices i.e. Radiation Therapy Oncology Group conformity
ndex (CIRTOG), the healthy tissue conformity index (HTCI),
nd the two-component conformity index (TCCI), etc.18 We
ecided, however not to apply the particular indices because
he study was carried out for the artiﬁcially shaped tumor
nly structures, that could not be checked well by conformity
ndices.
.  Results.1.  Film  calibration
ig. 3 shows the calibration curves for both ﬁlms. This curve
hows the relation between optical density and dose. As canctor detector for 1st case (cylindrical target).
be seen in the ﬁgure, response to radiation is higher on the EBT
ﬁlm than the RTQA ﬁlm. For example, at an irradiation dose of
dose of 1.5 Gy, the ROD for EBT and RTQA, respectively, were
0.395 and 0.262. The ﬁtted curves represented solid lines which
are asymptotes (y = a − b × cx). The ROD values were calculated
from the values of pixels in the red channel of the 48-bit scan.
4.2.  Graphical  comparison  of  dose  distributions
between  TPS  and  detectors
Figs. 4 and 5 compare the expected dose distribution (TPS) and
the doses measured by the semiconductor detectors for the
cylindrical (Fig. 4) and cuboidal (Fig. 5) targets. Black lines rep-
resent the calculated dose from the TPS and the red lines the
measured dose recorded by the detectors. The green line is
the tumor area. Bolded lines show the 95% isodose (2.85 Gy) of
the dose at the isocenter (3.00 Gy). Tumor volume is covered by
high dose of 95% for both analyzed shapes. TPS calculated dose
distribution for cuboidal target reference isodoses covered also
considerable area around the target.
Figs. 6–9 compare the dose distributions calculated by
the TPS and the distributions actually measured by the
Gafchromic ﬁlms for the cylindrical (Figs. 6 and 7) and cuboidal
(Figs. 8 and 9) targets. The black lines represent the calculated
dose by the TPS and the red lines – the measured dose recorded
by the RC ﬁlms. The green line is the tumor area. Only selected
isodoses are presented. The bold lines show the 95% isodose
of the maximum dose, which was normalized at 3.00 Gy  in the
isocenter.
We observed that for lower doses (10–50% of the prescribed
dose) for both targets were located at the same places, regard-
less of whether measurement was performed with a silicon
detector or RCF. For the ﬁrst target (the cylinder), 95% isodoses
included the target plus a small area outside but near the tar-
get whereas in the second case (the cuboids), 95% isodoses
(i.e., 2.85 Gy) included part of the target but also a larger area
near the target. Fig. 9 shows this well: the maximum dose of
3 Gy measured by RTQA ﬁlm lies outside the contoured tumor.
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Fig. 5 – Dose distributions of TPS and semiconductor detectors for 2nd case (cuboids).
 EBTFig. 6 – Dose distributions of TPS and
5.  Discussion
We  were able to measure the dose distribution in the entire
plane along the beam axis using both silicon detectors and
RCFs. However, dose distributions were more  precise with the
RCFs because these sheets are able to capture the dose over
the entire area of the ﬁlm whereas silicon detectors can only
measure the dose at a speciﬁc location, resulting in less precise
spatial resolution.
5.1.  Radiochromic  ﬁlms
The beneﬁts radiochromic ﬁlms are numerous. Originally
created as a replacement for silver halide radiographic ﬁlm
for use in quality assurance (QA) in intensity modulated
radiotherapy (IMRT), EBT ﬁlms are now widely used in var-
ious types of dosimetric QA.19 Unlike radiographic ﬁlms,
they are auto-developing, with the ﬁlm changing color in ﬁlm for 1st case (cylindrical target).
dose-dependent manner.20,21 Their thin and ﬂexible proﬁle
permits for sandwiching the ﬁlms between solid phantoms
of diverse geometric shapes, and they are also unaffected by
water and so are suitable for immersion in water phantoms.
Radiochromic ﬁlms are nearly tissue equivalent and spatial
resolution is high, thus making them ideal for measuring dose
distributions with steep dose gradients as occurs with the
Bragg peak in PBRT; according to Vatninski et al., RCF dosime-
try can detect misalignments >2 mm.15 Moreover, RCFs are
unaffected by standard room lights, although they are sensi-
tive to UV radiation in sunlight and glow-tube lighting.14,15,22
5.2.  Comparison  of  measured  and  calculated  dosesThe coverage of the target by reference isodose (95% of the
dose in the isocenter) was better for the cylindrical target
shape than for the cuboidal one. Of the three applied dosimet-
ric methods: EBT, RTQA, and semiconductors, the EBT ﬁlms
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Fig. 7 – Dose distributions of TPS and RTQA ﬁlm for 1st case (cylindrical target).
Fig. 8 – Dose distributions of TPS and EBT ﬁlm for 2nd case (cuboidal target).
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provided the dose distribution with best compliance, partic-
ularly for the cylindrical target. In contrast, the coverage of
the cylindrical target as revealed by the silicon detectors dif-
fered from a dose distribution calculated using the TPS by a
noticeable deviation.
In the cuboidal target, all types of detectors gave a good cov-
erage by a referential isodose, few ﬁndings to be highlighted.
The distributions measured by silicon detectors showed the
largest deviation from the TPS doses while RCF ﬁlms doses
ﬁtted the most.
5.3.  Usefulness  of  wax  boluses
Good compliance between the target shape and isodose cov-
erage, as revealed by the good coverage of the targets by 95%
isodose (shown in Figs. 4–9), supports the usefulness of wax
boluses. Nevertheless, the repeated measurements for the
structures created not only for the tumors but also represent-
ing critical organs would extend knowledge on usefulness and
accuracy of applied methodology.
The wax boluses used to modify proton beams at our center
have been proven to be suitable for modifying proton beam
range. They were able to accurately reproduce the distal age
of the tumor and dose distribution was good for targets with
streamlined shapes, which is crucial for treatment of brain
tumors where the dose must be precisely delivered.
6.  Conclusions
This study has shown that EBT radiochromic ﬁlms are accurate
and reliable manner to verify the dose distribution of proton
beams. We  conﬁrmed that the wax boluses creating and using
at our center provide dose distributions that are very close to
those calculated by the TPS. These results also show that the
TPS algorithm used at our center is correct.
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